. 2020 Sep 11;12(9):e10380. doi: 10.7759/cureus.10380

Table 2. Fibrosis score and ultrasound variables of HBV patients measured at three points in time.

T1- 1st time point (At the baseline, on the last medication administered just before switching to TAF)

T2- 2nd time point (at the time of switch)

T3- 3rd time point (6± 0.5 months after switching to TAF)

* For the comparison between the first and the third point in time (McNemar testing using binomial distribution)

** For the comparison between the second and the third point in time (McNemar testing using binomial distribution)

^_a _{One patient was excluded from this point due to the missing data}

_{HBV: hepatitis B virus}